Seeing Is Believing
Currently out of the existing stock ratings of Michael Sarcone, 5 are a HOLD (33.33%), 10 are a BUY (66.67%).
Analyst Michael Sarcone, currently employed at JEFFERIES, carries an average stock price target met ratio of 80% that have a potential upside of 15.28% achieved within 128 days.
Michael Sarcone’s has documented 29 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INSP, Inspire Medical Systems at 12-Feb-2026.
Analyst best performing recommendations are on EDAP (EDAP TMS SA).
The best stock recommendation documented was for EDAP (EDAP TMS SA) at 4/4/2025. The price target of $2 was fulfilled within 21 days with a profit of $0.39 (24.22%) receiving and performance score of 11.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Mar-2025
$55
$4.6 (9.13%)
$50
Buy Since 30-Sep-2025
$53
$2.6 (5.16%)
$50
Buy Since 17-Mar-2025
$50
$5.07 (11.28%)
$40
Buy Since 07-Dec-2023
$40
$-4.93 (-10.97%)
$37
Buy Since 01-Jul-2024
$36
$-8.93 (-19.88%)
What Year was the first public recommendation made by Michael Sarcone?